| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007441723 |
| P356 | DOI | 10.1186/1471-2407-9-25 |
| P932 | PMC publication ID | 2647942 |
| P698 | PubMed publication ID | 19154585 |
| P5875 | ResearchGate publication ID | 23802448 |
| P2093 | author name string | Ben Vainer | |
| Søren A Jensen | |||
| Mogens Kruhøffer | |||
| Jens B Sørensen | |||
| P2860 | cites work | Prognostic significance of microsatellite instability in sporadic colorectal cancer. | Q53639179 |
| Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. | Q54628312 | ||
| Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy | Q57567897 | ||
| Genetic heterogeneity of variable number tandem repeats in thymidylate synthase gene in colorectal cancer patients | Q63884150 | ||
| Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients | Q72313890 | ||
| Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer | Q73345126 | ||
| Microsatellite instability | Q73683104 | ||
| Proliferation, apoptosis, and survival in high-level microsatellite instability sporadic colorectal cancer | Q74321037 | ||
| Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study | Q79572431 | ||
| Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information | Q80357673 | ||
| Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer | Q80557773 | ||
| Thymidylate synthase expression in colon carcinomas with microsatellite instability | Q83289136 | ||
| High thymidylate synthase expression is typical for sporadic MSI-H colorectal carcinoma | Q83892137 | ||
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 | ||
| Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 | ||
| Cancer statistics, 2001 | Q28189339 | ||
| Systematic review of microsatellite instability and colorectal cancer prognosis | Q28303189 | ||
| Molecular predictors of survival after adjuvant chemotherapy for colon cancer | Q28363159 | ||
| Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Q29615026 | ||
| Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance | Q33245747 | ||
| Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer | Q33930691 | ||
| Thymidylate synthase expression in stage II and III colon cancer: a retrospective review | Q34501075 | ||
| Mismatch repair proficiency and in vitro response to 5-fluorouracil | Q35129256 | ||
| Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis | Q35643092 | ||
| Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer | Q35760529 | ||
| The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil | Q38435280 | ||
| Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up | Q38441178 | ||
| Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer | Q38449001 | ||
| Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma | Q38455394 | ||
| Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer | Q40418496 | ||
| Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma | Q40620362 | ||
| Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. | Q40687159 | ||
| MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast | Q42427955 | ||
| Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer | Q43722882 | ||
| Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy | Q43937145 | ||
| The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer | Q43960974 | ||
| Retrospective study on thymidylate synthase as a predictor of outcome and sensitivity to adjuvant chemotherapy in patients with curatively resected colorectal cancer | Q44190145 | ||
| DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study | Q44210955 | ||
| Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. | Q44295097 | ||
| Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone | Q44742955 | ||
| Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer. | Q44763095 | ||
| Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer. | Q44793209 | ||
| Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer. | Q45286673 | ||
| Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. | Q45957330 | ||
| High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies | Q46522716 | ||
| Microsatellite instability and colorectal cancer prognosis. | Q46831092 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| microsatellite | Q265193 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 25 | |
| P577 | publication date | 2009-01-20 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression | |
| P478 | volume | 9 |
| Q39422383 | ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. |
| Q36473730 | Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysis |
| Q53440447 | Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer. |
| Q37708008 | Circadian clock circuitry in colorectal cancer |
| Q43048728 | Correlation between thymidylate synthase gene variants, RNA and protein levels in primary colorectal adenocarcinomas |
| Q35773077 | Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. |
| Q58407923 | Frequent intragenic rearrangements of DPYD in colorectal tumours |
| Q38732716 | High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine |
| Q37581999 | Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation |
| Q34521714 | Multifaceted enrichment analysis of RNA-RNA crosstalk reveals cooperating micro-societies in human colorectal cancer |
| Q36964450 | Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer |
| Q58583909 | Prognostic Value of Mismatch Repair Genes for Patients With Colorectal Cancer: Meta-Analysis |
| Q26830362 | Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling? |
| Q35925275 | Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results |
| Q37137372 | Sputum-based molecular biomarkers for the early detection of lung cancer: limitations and promise |
| Q90295780 | The Prognostic and Predictive Value of Dihydropyrimidine Dehydrogenase-Related Indicators in Clinical Outcomes of Chemotherapy in Colorectal Cancer Patients: a Systematic Review and Meta-Analysis |
| Q44785500 | Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability. |
Search more.